I'm really happy I sold my SIPP IQE:IQE holding, as it has allowed me to massively increase my OPTI:Optibiotix holding, and that has increased more than IQE:IQE since I did the switch.
However I've been troubled ever since as my intention was to increase IQE:IQE rather than reduce.
I've been toying with selling something to fund some more, and put that into practice today.
I finally got rid of BDEV:Barratt Developments which is one of my oldest shares but has been making a loss since I bought them, particularly after Brexit. Today I sold my 100 shares for 625.13p making a loss of £59.42 (8.4%), but when you include dividends, my loss was only £1.12. I'm just glad to get shot of them - house builders are so volatile I find them too stressful to own. That liberated £613.18 towards my master plan.
Next I sold my share account holding of KIBO:Kibo Mining for 5.455p after buying them for 4.98p. Those 33,076 shares made me a small £95.54 (6.6%) profit. I still have 38,000 of these in my ISA but I paid 6.8p for those, so have a long way to go before they get in profit. This sale liberated £1,792.35. I believe in this company, but it is a high risk project and there's always a nagging doubt over the future of coal with the rapid rise in renewable energy, and there's no sign of getting free KAT:Katoro Mining shares in the near future, so IQE:IQE is a better bet I think.
My plan was to transfer the shares into my ISA when the settlement date arrives on Monday, so I'll be ready to strike on Tuesday if the interims trigger a big crash in IQE:IQE share price like they did after the last set of final results. Revenues are not that massive at the moment, even though potential revenues are vast, so this could trigger a wave of disappointment. Alternatively the outlook will be so rosy that the price soars, in which case I'll celebrate the increase in my current holding and buy something else instead.
I have changed my plans slightly. I now intend to transfer the cash to my SIPP, as £2,400 will generate £600 revenue from the taxman and I don't need to get at this cash in a hurry.
Today was a great day with nearly everything blue. Good job, as yesterday the combined portfolios were down over £1,200 on last week, whereas today they are £113 up. Let's hope for another good day tomorrow to stay in the black, and then it's a waiting game until Tuesday when I find out if I get a chance to buy some more IQE:IQE.
Thursday 31 August 2017
Sunday 27 August 2017
Week 107 Review - Significant milestone reached
Another great week, with my key holdings performing absolutely brilliantly. It was almost a record week, with the difference between cost and value improving by £4,040 extending my "in the black" buffer to £5,097. The significant milestone is the combined portfolio value going above £75,000 to £75,207. It's just a case of watching to see if the rise is sustainable.
Worst performer was TRX:Tissue Regenix which dropped 10% just as I thought it had turned around and was heading in the right direction. This is now down by 38% and losing £684. Seems a long time since I regretted selling my ISA holding for only £71 profit, but now I'm relieved I did.
OPTI:Optibiotix is doing very well dragging itself out of the mire, with a run of really positive news releases. My holdings were up by 11% this week and are now in paper profit of £956 which means in a few weeks it's gone from Nemesis Share to one of my best performers.
CWR:Ceres Power Holdings had a great week, up 17% and now up by 53% on my purchase price. The potential profit has gone up to £964 and I wish I had funds to get some more.
SBTX:SkinBioTherapeutics rose by 18% which is fantastic, but the holding is still down by 21% and losing £222 so a way to go before I'll be really happy.
Share of the Week is IQE:IQE yet again. They had a bad one last week, but were back to normal this week, with my holding increasing in value by 41% on the cost price to go 364% up making £7,120 potential profit on a £1,956 investment. Yippee!
The value over cost gap is back up to the widest it's ever been, despite the cost having risen significantly.
Here's the ISA and share accounts
Value up by £2,462 of which most was decresing losses, as OPTI:Optibiotix is still making a loss in the ISA and SBTX:Skinbiotherapeutics is also reduced losses. The increased profits are largely down to IQE:IQE and CWR:Ceres Power, but a dropping AMYT:Amryt Pharma took some of the increased profits away. Projected year 3 average monthly performance is rapidly dropping after the GVC:GVC Holdings sale in week 1 caused the stats to go wild.
Nice spike! Will it hold this time - it doesn't usually...
The SIPP looks like this after week 91
Normality returns after last week's massive IQE:IQE sale. OPTI:Optibiotix shook off all its losses and moved into profit, and CAML:Central Asia Metals also had a small tick up to help. TRX:Tissue Regenix let the side down. Average monthly performance after nearly 2 years is twice my target, and the paper value is 10% up too, so this account is deeply satisfying.
I was worried about staying in the black after the sale, but most of the buffer has been restored already.
The trading account looks like this after week 47
I have started recording year 2 stats now, but seeing as there aren't any, I don't think I'll bother putting them in the table unless something actually happens, which given the track record of this account isn't very likely.
At least it's reasonably consistent...
There are only 4 trading days next week so not sure if much will happen. The main focus is on 5th September when IQE:IQE announce their 6 month results. Last time they announced results the share price tanked for 2 days before bouncing back and heading on its dizzy climb. I'm hoping this will happen again and looking to get some cash available if it does. If it doesn't then I might be tempted with a few more OPTI:Optibiotix. My cunning plan is to sell BDEV:Barratt Developments if it gets a teensy bit closer to break-even, and to sell KIBO:Kibo Mining from my share account if it ticks up the 0.25p I need to make a bit of profit. If that happens early enough next week I can transfer about £2,000 to my ISA before Wednesday and be prepared to strike. I'll still have plenty of KIBO:Kibo Mining in my ISA as I believe it's going to be great, but it's quite high risk whereas IQE:IQE isn't.
The week after next is doubly exciting because AMYT:Amryt Pharma announce 6-month results on 4th September and if there's any sign of early revenue from the recent distribution deal for Lojuxta then things could get quite tasty. This is my 2nd biggest holding after OPTI:Optibiotix at 9% of my portfolio so a small rise can be quite spectacular.
Just got to get next week out of the way first...
Worst performer was TRX:Tissue Regenix which dropped 10% just as I thought it had turned around and was heading in the right direction. This is now down by 38% and losing £684. Seems a long time since I regretted selling my ISA holding for only £71 profit, but now I'm relieved I did.
OPTI:Optibiotix is doing very well dragging itself out of the mire, with a run of really positive news releases. My holdings were up by 11% this week and are now in paper profit of £956 which means in a few weeks it's gone from Nemesis Share to one of my best performers.
CWR:Ceres Power Holdings had a great week, up 17% and now up by 53% on my purchase price. The potential profit has gone up to £964 and I wish I had funds to get some more.
SBTX:SkinBioTherapeutics rose by 18% which is fantastic, but the holding is still down by 21% and losing £222 so a way to go before I'll be really happy.
Share of the Week is IQE:IQE yet again. They had a bad one last week, but were back to normal this week, with my holding increasing in value by 41% on the cost price to go 364% up making £7,120 potential profit on a £1,956 investment. Yippee!
The value over cost gap is back up to the widest it's ever been, despite the cost having risen significantly.
Here's the ISA and share accounts
| Weekly Change | |||
| Portfolio cost | £46,796.25 | +£0 | |
| Portfolio sell value (bid price - commission) | £49,686.97 | (+6.2%) | +£2,462.99 |
| Potential profits | £8,610.17 | +£930.21 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £549.25 | +£0 | |
| Yr 3 Average monthly cash profit | £728.34 | (18.7%) | -£364.17 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,261.74 | +£0 | |
| Average monthly cash profit | £337.57 | (8.7%) | -£3.19 |
| (Sold stocks profit + Dividends - Fees / Months) |
Value up by £2,462 of which most was decresing losses, as OPTI:Optibiotix is still making a loss in the ISA and SBTX:Skinbiotherapeutics is also reduced losses. The increased profits are largely down to IQE:IQE and CWR:Ceres Power, but a dropping AMYT:Amryt Pharma took some of the increased profits away. Projected year 3 average monthly performance is rapidly dropping after the GVC:GVC Holdings sale in week 1 caused the stats to go wild.
Nice spike! Will it hold this time - it doesn't usually...
The SIPP looks like this after week 91
| Weekly Change | |||
| Portfolio cost | £22,828.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £25,190.23 | (10.3%) | +£1,574.55 |
| Potential profits | £3,448.39 | +£1,304.14 | |
| Yr 2 Dividends | £294.96 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £756.01 | (39.7%) | -£19.89 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £453.16 | (23.8%) | -£5.04 |
| (Sold stocks profit + Dividends - Fees / Months) |
Normality returns after last week's massive IQE:IQE sale. OPTI:Optibiotix shook off all its losses and moved into profit, and CAML:Central Asia Metals also had a small tick up to help. TRX:Tissue Regenix let the side down. Average monthly performance after nearly 2 years is twice my target, and the paper value is 10% up too, so this account is deeply satisfying.
I was worried about staying in the black after the sale, but most of the buffer has been restored already.
The trading account looks like this after week 47
| Weekly Change | |||
| Portfolio cost | £486.05 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £329.99 | (-31.9%) | +£2.78 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.65 | (-4.1%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
I have started recording year 2 stats now, but seeing as there aren't any, I don't think I'll bother putting them in the table unless something actually happens, which given the track record of this account isn't very likely.
At least it's reasonably consistent...
There are only 4 trading days next week so not sure if much will happen. The main focus is on 5th September when IQE:IQE announce their 6 month results. Last time they announced results the share price tanked for 2 days before bouncing back and heading on its dizzy climb. I'm hoping this will happen again and looking to get some cash available if it does. If it doesn't then I might be tempted with a few more OPTI:Optibiotix. My cunning plan is to sell BDEV:Barratt Developments if it gets a teensy bit closer to break-even, and to sell KIBO:Kibo Mining from my share account if it ticks up the 0.25p I need to make a bit of profit. If that happens early enough next week I can transfer about £2,000 to my ISA before Wednesday and be prepared to strike. I'll still have plenty of KIBO:Kibo Mining in my ISA as I believe it's going to be great, but it's quite high risk whereas IQE:IQE isn't.
The week after next is doubly exciting because AMYT:Amryt Pharma announce 6-month results on 4th September and if there's any sign of early revenue from the recent distribution deal for Lojuxta then things could get quite tasty. This is my 2nd biggest holding after OPTI:Optibiotix at 9% of my portfolio so a small rise can be quite spectacular.
Just got to get next week out of the way first...
Wednesday 23 August 2017
Optibiotix back in profit!
Oh happy day!
Mainly thanks to sinking most of my IQE:IQE profits into OPTI:Optibiotix at just under 60p last week, today's rise of the bid price by 4p to 69p has changed what was a £4,500 paper loss a few weeks ago into a £516 profit today.
My SIPP holding received all the new shares and now stands at 21,458 with an average cost of 64.64p. These are making £837 potential profit.
My share account holding is just 2,044 shares with an average price of 65.89p and making £42 profit. I want to transfer these to my ISA but daren't in case it invalidates any free SBTX:Skinbiotherapeutics shares if the qualification date is back-dated.
My ISA is letting the side down, with 20,458 shares at an average price of 70.28p. These are still losing £363 - but for how much longer?
So although the last few years, and most especially the last few weeks, have been very trying and frustrating, they have done me a massive favour, as I've been able to accumulate a ridiculous amount of shares that I wouldn't have even considered if the price had sneaked up gradually. IQE:IQE is a perfect example - I know I should have been buying more, but as the price kept going up I found excuses not to - or at least decided OPTI:Optibiotix was better value when the price dipped.
As a result of that accumulation, the potential here is exponentially more than it would have been had the price behaved more rationally.
Yesterday's announcement of the enhanced deal with SACCO was stunning. Not only does it open up the American market which is surely a prerequisite for any deals with a multinational, but it opens up the dairy market. Probiotic yogurts are massive, but health claims are a bit wishy-washy. Get LP-LDL in there and open up real tangible health benefits.
I really hope this time my holding stays in profit and we can maintain at least 70p until the news of big contracts is released.
At the mid-week point my portfolio is looking very healthy. The timing of the IQE:IQE sale was perfect for both OPTI:Optibiotix and CAML:Central Asia Metals which has risen well on the increased copper price, now making £1,872 profit.
The combined portfolios are £2,967 up on last week, with the buffer between value and cost up to £4,025 and the portfolio value standing at a record £74,134. To give some context, it was less than a month ago on 28th July I reported that the portfolio was at an all time high of £68,162. That's £6,000 rise in less than a month!
I think that deserves a "Woohoo!"
Mainly thanks to sinking most of my IQE:IQE profits into OPTI:Optibiotix at just under 60p last week, today's rise of the bid price by 4p to 69p has changed what was a £4,500 paper loss a few weeks ago into a £516 profit today.
My SIPP holding received all the new shares and now stands at 21,458 with an average cost of 64.64p. These are making £837 potential profit.
My share account holding is just 2,044 shares with an average price of 65.89p and making £42 profit. I want to transfer these to my ISA but daren't in case it invalidates any free SBTX:Skinbiotherapeutics shares if the qualification date is back-dated.
My ISA is letting the side down, with 20,458 shares at an average price of 70.28p. These are still losing £363 - but for how much longer?
So although the last few years, and most especially the last few weeks, have been very trying and frustrating, they have done me a massive favour, as I've been able to accumulate a ridiculous amount of shares that I wouldn't have even considered if the price had sneaked up gradually. IQE:IQE is a perfect example - I know I should have been buying more, but as the price kept going up I found excuses not to - or at least decided OPTI:Optibiotix was better value when the price dipped.
As a result of that accumulation, the potential here is exponentially more than it would have been had the price behaved more rationally.
Yesterday's announcement of the enhanced deal with SACCO was stunning. Not only does it open up the American market which is surely a prerequisite for any deals with a multinational, but it opens up the dairy market. Probiotic yogurts are massive, but health claims are a bit wishy-washy. Get LP-LDL in there and open up real tangible health benefits.
I really hope this time my holding stays in profit and we can maintain at least 70p until the news of big contracts is released.
At the mid-week point my portfolio is looking very healthy. The timing of the IQE:IQE sale was perfect for both OPTI:Optibiotix and CAML:Central Asia Metals which has risen well on the increased copper price, now making £1,872 profit.
The combined portfolios are £2,967 up on last week, with the buffer between value and cost up to £4,025 and the portfolio value standing at a record £74,134. To give some context, it was less than a month ago on 28th July I reported that the portfolio was at an all time high of £68,162. That's £6,000 rise in less than a month!
I think that deserves a "Woohoo!"
Saturday 19 August 2017
Week 106 Review - Massive increase in Optibiotix holding
What an exciting week! The big headline was selling half my IQE:IQE shares in order to take advantage of the crazy dip in OPTI:Optibiotix. I'm happy to say it's paying off so far. Total portfolio value has smashed through previous records by £3,000 to hit £71,166. The profit-taking did immediately put my paper profits down by nearly £5,000 but by the end of the week the difference between cost price and value was only £1,853 down, so well over half had been clawed back. The combined portfolios are back in the black, with a small buffer of £1,057.
Worst performer this week was IQE:IQE, suffering from profit taking (including me!) and dropping 11% in my ISA, but who cares when it's still 323% up?
It's with unparalleled joy that I can say the best performer this week was OPTI:Optibiotix. My ISA holding increased by 8%, but thanks to buying a massive chunk at 59.95p, my SIPP holding climbed in value by 16%. I now hold 43,960 shares across three accounts costing £29,779 and currently losing £2,120. However, that's half what it was losing last week and each 1p rise is now worth £439. If it gets to 100p a share I'll be sitting on £14,000 profit and that's only my very short term target. When shares in SBTX:SkinBiotherapeutics get distributed and hopefully Sweetbiotix further down the line, the compounding could be spectacular.
Staying in the black was a priority and it just about worked.
The ISA and share accounts looks like this
Very interesting - potential profits are down £77 thanks to the drop in IQE:IQE but small increases elsewhere limited the damage. Most of the £1,240 increase is thanks to OPTI:Optibiotix. Year 3 projected performance is skewed horribly by selling GVC:GVC Holdings in week 1, so that will come tumbling down every week now. Overall performance slips a tiny amount and although 8.7% is below target, it's not so bad I'm worrying.
Up and down like a yo-yo
The SIPP looks like this after week 90
Where to start? The £4,978 increase in realised profits came from selling IQE:IQE and that massively boosted my average performance by over 100% to £458 per month (24.1%). This was immediately re-invested mainly in OPTI:Optibiotix but also CAML:Central Asia Metals, both of which had decent rises this week.
Although potential profits declined by £4,100 that actually means an £875 improvement when you remove the sale mainly thanks to CAML:Central Asia Metals. Even better than that, the sell value is only down by £3,093 having taken into account the increase in cost, which means around £1,900 of the damage inflicted by the sale has been clawed back, mainly through reducing OPTI:Optibiotix losses. All in all very satisfying.
What a spike! I really didn't expect to stay in the black, so very very happy with this.
The trading account looks like this after week 56
No change at all - not even worth talking about
Ditto
I have a bit of a dilemma with IQE:IQE now. I actually wanted to buy more, but ended up halving my holding. The timing was good as there has been a drop-off, but with the iPhone 8 about to launch and interims on 5th September, the drop could be short lived.
I do have a few options. In my standard share account, BDEV:Barratt Developments is only losing £16.75 if you include the dividends so I could liberate £600 for a small chunk of IQE:IQE. I also have £1,800 worth of KIBO:KIBO Mining in my share account which is in profit, but I wanted to hold those for free KAT:Katoro Gold shares. The question is, how much higher risk is an African coal mine compared to a Welsh semi-conductor manufacturer? Quite a lot I think. I still have over £2,000 KIBO:Kibo Mining in my ISA so would maintain an interest.
The other big possibility is LOOK:Lookers which has never recovered from Brexit and is still losing £800. However this is trading on a P/E ratio of 5 which is crazy. I could liberate £1,200 but not sure I can stomach such a big loss on a good company which will surely re-rate soon.
Let's see what next week brings...
Worst performer this week was IQE:IQE, suffering from profit taking (including me!) and dropping 11% in my ISA, but who cares when it's still 323% up?
It's with unparalleled joy that I can say the best performer this week was OPTI:Optibiotix. My ISA holding increased by 8%, but thanks to buying a massive chunk at 59.95p, my SIPP holding climbed in value by 16%. I now hold 43,960 shares across three accounts costing £29,779 and currently losing £2,120. However, that's half what it was losing last week and each 1p rise is now worth £439. If it gets to 100p a share I'll be sitting on £14,000 profit and that's only my very short term target. When shares in SBTX:SkinBiotherapeutics get distributed and hopefully Sweetbiotix further down the line, the compounding could be spectacular.
Staying in the black was a priority and it just about worked.
The ISA and share accounts looks like this
| Weekly Change | |||
| Portfolio cost | £46,796.25 | +£0 | |
| Portfolio sell value (bid price - commission) | £47,223.98 | (+0.9%) | +£1,240.53 |
| Potential profits | £7,679.96 | -£77.44 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £549.25 | +£0 | |
| Yr 3 Average monthly cash profit | £1,092.51 | (28%) | -£1,092.51 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,261.74 | +£0 | |
| Average monthly cash profit | £340.76 | (8.7%) | -£3.24 |
| (Sold stocks profit + Dividends - Fees / Months) |
Very interesting - potential profits are down £77 thanks to the drop in IQE:IQE but small increases elsewhere limited the damage. Most of the £1,240 increase is thanks to OPTI:Optibiotix. Year 3 projected performance is skewed horribly by selling GVC:GVC Holdings in week 1, so that will come tumbling down every week now. Overall performance slips a tiny amount and although 8.7% is below target, it's not so bad I'm worrying.
Up and down like a yo-yo
The SIPP looks like this after week 90
| Weekly Change | |||
| Portfolio cost | £22,828.63 | +£4,975.63 | |
| Portfolio sell value (bid price - commission) | £23,615.68 | (3.4%) | -£3,093.73 |
| Potential profits | £2,144.25 | -£4,100.60 | |
| Yr 2 Dividends | £294.96 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£4,978.52 | |
| Yr 2 Average monthly cash profit | £775.900 | (40.8%) | +£562.10 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£4,978.52 | |
| Average monthly cash profit | £458.20 | (24.1%) | +£237.25 |
| (Sold stocks profit + Dividends - Fees / Months) |
Where to start? The £4,978 increase in realised profits came from selling IQE:IQE and that massively boosted my average performance by over 100% to £458 per month (24.1%). This was immediately re-invested mainly in OPTI:Optibiotix but also CAML:Central Asia Metals, both of which had decent rises this week.
Although potential profits declined by £4,100 that actually means an £875 improvement when you remove the sale mainly thanks to CAML:Central Asia Metals. Even better than that, the sell value is only down by £3,093 having taken into account the increase in cost, which means around £1,900 of the damage inflicted by the sale has been clawed back, mainly through reducing OPTI:Optibiotix losses. All in all very satisfying.
What a spike! I really didn't expect to stay in the black, so very very happy with this.
The trading account looks like this after week 56
| Weekly Change | |||
| Portfolio cost | £486.05 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £327.21 | (-32.7%) | +£0 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.68 | (-4.2%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
No change at all - not even worth talking about
Ditto
I have a bit of a dilemma with IQE:IQE now. I actually wanted to buy more, but ended up halving my holding. The timing was good as there has been a drop-off, but with the iPhone 8 about to launch and interims on 5th September, the drop could be short lived.
I do have a few options. In my standard share account, BDEV:Barratt Developments is only losing £16.75 if you include the dividends so I could liberate £600 for a small chunk of IQE:IQE. I also have £1,800 worth of KIBO:KIBO Mining in my share account which is in profit, but I wanted to hold those for free KAT:Katoro Gold shares. The question is, how much higher risk is an African coal mine compared to a Welsh semi-conductor manufacturer? Quite a lot I think. I still have over £2,000 KIBO:Kibo Mining in my ISA so would maintain an interest.
The other big possibility is LOOK:Lookers which has never recovered from Brexit and is still losing £800. However this is trading on a P/E ratio of 5 which is crazy. I could liberate £1,200 but not sure I can stomach such a big loss on a good company which will surely re-rate soon.
Let's see what next week brings...
Monday 14 August 2017
Time to take some IQE profits
Over the weekend I decided to take some of my IQE:IQE profits.
I was dwelling over something I wrote about OPTI:Optibiotix in my blog on Friday.
"That doesn't take away the hurt of these short term losses, or the knowledge that someone could stroll up today and get a massive load cheaper than any I've bought and reap all the same rewards without the 2 years of anguish."
There is a way I could acquire an absolutely massive load myself at these crazy prices...
The IQE:IQE shares in my SIPP were a bit of an afterthought, and I'm fed up of losing my gains on AIM shares as the price gets manipulated. Add to that the sudden increase in shorting activity and I got the jitters. I'll keep my main holding in the ISA and bank the profit in my SIPP to use for a huge increase in my OPTI:Optibiotix holding.
I sold my 5,561 shares for 137.42p making £4,978.52 (186.9%) profit. Not bad! That's more profit than I've made on all my SIPP sales combined.
I bought another 10,701 shares in OPTI:Optibiotix for the ludicrous 59.95p costing £6,427.20 and bringing my SIPP average price down from around 69p to 64.6p. This means OPTI:Optibiotix now comprises 42.5% of my portfolio - so I had better be right about its prospects!
Another bonus was I had some spare cash to increase my holding in my favourite company CAML:Central Asia Metals. I bought another 544 shares at 218.2799p costing £1,199.39. This takes my total holding to 2,678 shares with an average price of 170.99p and making £1,142 (25%) profit. If you add the £473 dividends I've had in 2 years the return has been 35% so it's about time I got some more of these, especially with the price of copper on the rise and some new projects in the pipeline.
There is a fairly major negative side to today's transaction - the profits have been taken off my paper profits and plunged my combined portfolios £1,993 into the red when comparing value to cost. Even the SIPP has gone into paper loss for the first time in ages. Although the value of the combined portfolios has stayed at £68,000 the cost has gone up above £70,000. This is a bit of a milestone, but I need some lagging shares to turn around to get back into paper black.
So I'm sad to lose almost half my IQE:IQE holding, but delirious at the massive profits, the chance to get more CAML:Central Asia Metals and most importantly a whopping great bargain bucket of OPTI:Optibiotix shares which will soon propell the portfolio into the stratosphere...
I was dwelling over something I wrote about OPTI:Optibiotix in my blog on Friday.
"That doesn't take away the hurt of these short term losses, or the knowledge that someone could stroll up today and get a massive load cheaper than any I've bought and reap all the same rewards without the 2 years of anguish."
There is a way I could acquire an absolutely massive load myself at these crazy prices...
The IQE:IQE shares in my SIPP were a bit of an afterthought, and I'm fed up of losing my gains on AIM shares as the price gets manipulated. Add to that the sudden increase in shorting activity and I got the jitters. I'll keep my main holding in the ISA and bank the profit in my SIPP to use for a huge increase in my OPTI:Optibiotix holding.
I sold my 5,561 shares for 137.42p making £4,978.52 (186.9%) profit. Not bad! That's more profit than I've made on all my SIPP sales combined.
I bought another 10,701 shares in OPTI:Optibiotix for the ludicrous 59.95p costing £6,427.20 and bringing my SIPP average price down from around 69p to 64.6p. This means OPTI:Optibiotix now comprises 42.5% of my portfolio - so I had better be right about its prospects!
Another bonus was I had some spare cash to increase my holding in my favourite company CAML:Central Asia Metals. I bought another 544 shares at 218.2799p costing £1,199.39. This takes my total holding to 2,678 shares with an average price of 170.99p and making £1,142 (25%) profit. If you add the £473 dividends I've had in 2 years the return has been 35% so it's about time I got some more of these, especially with the price of copper on the rise and some new projects in the pipeline.
There is a fairly major negative side to today's transaction - the profits have been taken off my paper profits and plunged my combined portfolios £1,993 into the red when comparing value to cost. Even the SIPP has gone into paper loss for the first time in ages. Although the value of the combined portfolios has stayed at £68,000 the cost has gone up above £70,000. This is a bit of a milestone, but I need some lagging shares to turn around to get back into paper black.
So I'm sad to lose almost half my IQE:IQE holding, but delirious at the massive profits, the chance to get more CAML:Central Asia Metals and most importantly a whopping great bargain bucket of OPTI:Optibiotix shares which will soon propell the portfolio into the stratosphere...
Friday 11 August 2017
Week 105 Review - Crappy Friday
This should have been an amazing week. I was set for a really upbeat blog today, but along comes another crappy Friday and ruins everything. I should be celebrating a massive gain for IQE:IQE, but instead I'm furious at the complete collapse of the OPTI:Optibiotix share price which has wiped out all the gains and left the week at a loss. The combined portfolios are down by £513.89 and the buffer keeping me in the black narrowed to £2,910. The total portfolio value is £68,044 which is almost a record high, as the profits from GVC:GVC Holdings have been re-invested. Without the sale, the performance would actually be £36 in the black so maybe I shouldn't be too upset - but I am!
OPTI:Optibiotix was the only double digit loser, dropping by 10% and deepening my losses by about £2,000 to £4,430. I kept topping up over the last few months at what I thought were stupidly cheap prices, only for them to get even cheaper. After nearly 2 years of frustration, today has just about pushed me to the edge of my patience. I know this is a great company, I know that profits are about to appear, I know there are free shares in SBTX:Skinbiotherapeutics coming soon, and I know Sweetbiotix will be utterly massive. That doesn't take away the hurt of these short term losses, or the knowledge that someone could stroll up today and get a massive load cheaper than any I've bought and reap all the same rewards without the 2 years of anguish.
Never mind eh...
There were a few other biggish losers, with TND:Tandem Group dropping 8% on no volume whatsoever, and more painfully AMYT:Amryt Pharma dropping 6% which was a significant contributor to this week's losses
One bit of great news was TRX:Tissue Regenix finally woke up and climbed 13%. This is still down by 30% but there may be some momentum now after buying out an American (profit-making) company.
Share of the Week should come as no surprise. IQE:IQE is utterly wonderful, with the SIPP holding increasing in value by 46% to go 172% up, and even more impressive was the ISA holding, increasing in value by 74% and now up by 334% on the purchase price. Combined paper profits are now £11,082 and are single-handedly saving my portfolio performance.
Cost price goes up but value doesn't. Where the hell would I be without IQE:IQE?!
Here's the performance of the ISA and share accounts
A somewhat complex picture! Portfolio cost increased by £549.57 after re-investing the proceeds from selling GVC:GVC Holdings, which I'm slightly relieved to say have crashed by 37p a share since I sold them. If you take that out of the picture, the portfolio value dropped by £1,119.76 mostly thanks to OPTI:Optibiotix and AMYT:Amryt Pharma. The increased profits of IQE:IQE helped prop things up, with potential profits climbing by £493 but it would have been double if I hadn't sold GVC:GVC Holdings despite their drop, and even more if AMYT:Amryt Pharma hadn't dropped by 6%.
This is week 1 of year 3 so we start again from scratch, and if all 52 weeks are like this week I'll be making £2,185 a month. That certainly won't happen but it gives me a massive buffer before I need to sell anything in order to stay at my 10% forecast target. Overall profits increased by £19 a month and take me to 8.8%. When I first sold GVC:GVC Holdings I thought my performance had increased to 9.8%, but I stupidly did the calculation before buying the new shares, which increased the size of the portfolio by over £4,000 and corrected the performance figure. It's still 0.4% better than last week though. Unfortunately these accounts have dropped back into the red by £614.
I really hope this doesn't do another one of those nose-dives for the next few weeks.
Here's the SIPP performance after week 89
Good old SIPP. The exposure to OPTI:Optibiotix isn't as great, so although the increase in potential profits of £1,118 was almost halved by the deepening losses, everything still looks very healthy.
Big wide gap of loveliness.
The poxy tradng account looks like this after week 55
I suppose I should add year 2 figures into here, but I really couldn't be arsed. A 2p share price increase for REDS:RedstoneConnect reduced the losses by a fiver - yippee!
Hrumph.
Right - I've had enough - well done IQE:IQE you are wonderful. Bad, naughty OPTI:Optibiotix you are in the dog house tonight. Please, please, please, please, please give us some news next week that turns the share price around...
OPTI:Optibiotix was the only double digit loser, dropping by 10% and deepening my losses by about £2,000 to £4,430. I kept topping up over the last few months at what I thought were stupidly cheap prices, only for them to get even cheaper. After nearly 2 years of frustration, today has just about pushed me to the edge of my patience. I know this is a great company, I know that profits are about to appear, I know there are free shares in SBTX:Skinbiotherapeutics coming soon, and I know Sweetbiotix will be utterly massive. That doesn't take away the hurt of these short term losses, or the knowledge that someone could stroll up today and get a massive load cheaper than any I've bought and reap all the same rewards without the 2 years of anguish.
Never mind eh...
There were a few other biggish losers, with TND:Tandem Group dropping 8% on no volume whatsoever, and more painfully AMYT:Amryt Pharma dropping 6% which was a significant contributor to this week's losses
One bit of great news was TRX:Tissue Regenix finally woke up and climbed 13%. This is still down by 30% but there may be some momentum now after buying out an American (profit-making) company.
Share of the Week should come as no surprise. IQE:IQE is utterly wonderful, with the SIPP holding increasing in value by 46% to go 172% up, and even more impressive was the ISA holding, increasing in value by 74% and now up by 334% on the purchase price. Combined paper profits are now £11,082 and are single-handedly saving my portfolio performance.
Cost price goes up but value doesn't. Where the hell would I be without IQE:IQE?!
Here's the performance of the ISA and share accounts
| Weekly Change | |||
| Portfolio cost | £46,796.25 | +£549.57 | |
| Portfolio sell value (bid price - commission) | £45,983.45 | (-1.7%) | -£1,119.76 |
| Potential profits | £7,757.40 | +£493.28 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £549.25 | +£549.25 | |
| Yr 3 Average monthly cash profit | £2,185.02 | (56%) | +£2,185.02 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,261.74 | +£549.24 | |
| Average monthly cash profit | £344.00 | (8.8%) | +£19.57 |
| (Sold stocks profit + Dividends - Fees / Months) |
A somewhat complex picture! Portfolio cost increased by £549.57 after re-investing the proceeds from selling GVC:GVC Holdings, which I'm slightly relieved to say have crashed by 37p a share since I sold them. If you take that out of the picture, the portfolio value dropped by £1,119.76 mostly thanks to OPTI:Optibiotix and AMYT:Amryt Pharma. The increased profits of IQE:IQE helped prop things up, with potential profits climbing by £493 but it would have been double if I hadn't sold GVC:GVC Holdings despite their drop, and even more if AMYT:Amryt Pharma hadn't dropped by 6%.
This is week 1 of year 3 so we start again from scratch, and if all 52 weeks are like this week I'll be making £2,185 a month. That certainly won't happen but it gives me a massive buffer before I need to sell anything in order to stay at my 10% forecast target. Overall profits increased by £19 a month and take me to 8.8%. When I first sold GVC:GVC Holdings I thought my performance had increased to 9.8%, but I stupidly did the calculation before buying the new shares, which increased the size of the portfolio by over £4,000 and corrected the performance figure. It's still 0.4% better than last week though. Unfortunately these accounts have dropped back into the red by £614.
I really hope this doesn't do another one of those nose-dives for the next few weeks.
Here's the SIPP performance after week 89
| Weekly Change | |||
| Portfolio cost | £17,853.50 | +£0 | |
| Portfolio sell value (bid price - commission) | £21,734.28 | (21.7%) | +£600.32 |
| Potential profits | £6,244.85 | +£1,118.18 | |
| Yr 2 Dividends | £294.96 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£0 | |
| Yr 2 Average monthly cash profit | £213.80 | (14.4%) | -£6.93 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £3,946.67 | +£0 | |
| Average monthly cash profit | £220.95 | (14.9%) | -£2.91 |
| (Sold stocks profit + Dividends - Fees / Months) |
Good old SIPP. The exposure to OPTI:Optibiotix isn't as great, so although the increase in potential profits of £1,118 was almost halved by the deepening losses, everything still looks very healthy.
Big wide gap of loveliness.
The poxy tradng account looks like this after week 55
| Weekly Change | |||
| Portfolio cost | £486.05 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £327.21 | (-32.5%) | +£5.56 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.71 | (-4.2%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
I suppose I should add year 2 figures into here, but I really couldn't be arsed. A 2p share price increase for REDS:RedstoneConnect reduced the losses by a fiver - yippee!
Hrumph.
Right - I've had enough - well done IQE:IQE you are wonderful. Bad, naughty OPTI:Optibiotix you are in the dog house tonight. Please, please, please, please, please give us some news next week that turns the share price around...
Wednesday 9 August 2017
IQE slips through the fingers
I've been waiting all week for IQE:IQE to drop back to Friday's level so I can top up with the proceeds from selling GVC:GVC Holdings on Monday.
It was with great despair that I saw the price had gone up to 130p at lunchtime. If I had bought immediately on Monday I'd be well up by now!
IQE:IQE currently stands at £5,924 (303%) profit on a £1,956 investment in my ISA, so I'm loathe to risk buying on a spike as it will horribly compromise that statistic if the price then falls, whereas at the moment the worst that can happen is a drop to a mere 250% profit or so.
The SIPP holding is making £4,037 (153%) profit on a £2,651 investment so IQE:IQE is making me nearly £10,000 paper profit on its own. That shows how badly the rest of the portfolio is performing!
Take note OPTI:Optibiotix!
I decided not to sit on my pot of cash in the hope IQE:IQE drops enough for me to buy more. This could be a terrible, terrible mistake, but if it is, then I've made it.
Instead I bought back into TLOU:Tlou Energy, purchasing 15,634 shares at 8.772p at a cost of £1,383.36.
I sold my remaining holding a few weeks ago at 9.322p and made £380 (69.1%) profit, and I pretty much regretted selling them immediately. If IQE:IQE won't drop to an acceptable price, then I'm satisfied TLOU:Tlou Energy have done.
My reasons for investing here haven't changed. A very strong management team who have created big companies in the past, a big local market for their gas and a government very keen to see their proposed power station happen.
That's all my profits used up so no more buying for a while.
This week is looking pretty flat so far, which is actually up by over £500 when you consider the big GVC:GVC Holdings sale erasing a chunk of paper profit. JLP:Jubilee Platinum had a healthy 9.5% increase today after announcing $50m financing for new projects. OPTI:Optibiotix had another depressing drop, and even IQE:IQE were very naughty, as my disappointment at missing out on the purchase was tempered by an 8p rise in share price, until I got home and found all today's gains had vanished by close of play. If the price tanks now then I may not be holding TLOU:Tlou Energy very long so I can revert to plan A!
It's been a busy week already - and still 2 days to go...
It was with great despair that I saw the price had gone up to 130p at lunchtime. If I had bought immediately on Monday I'd be well up by now!
IQE:IQE currently stands at £5,924 (303%) profit on a £1,956 investment in my ISA, so I'm loathe to risk buying on a spike as it will horribly compromise that statistic if the price then falls, whereas at the moment the worst that can happen is a drop to a mere 250% profit or so.
The SIPP holding is making £4,037 (153%) profit on a £2,651 investment so IQE:IQE is making me nearly £10,000 paper profit on its own. That shows how badly the rest of the portfolio is performing!
Take note OPTI:Optibiotix!
I decided not to sit on my pot of cash in the hope IQE:IQE drops enough for me to buy more. This could be a terrible, terrible mistake, but if it is, then I've made it.
Instead I bought back into TLOU:Tlou Energy, purchasing 15,634 shares at 8.772p at a cost of £1,383.36.
I sold my remaining holding a few weeks ago at 9.322p and made £380 (69.1%) profit, and I pretty much regretted selling them immediately. If IQE:IQE won't drop to an acceptable price, then I'm satisfied TLOU:Tlou Energy have done.
My reasons for investing here haven't changed. A very strong management team who have created big companies in the past, a big local market for their gas and a government very keen to see their proposed power station happen.
That's all my profits used up so no more buying for a while.
This week is looking pretty flat so far, which is actually up by over £500 when you consider the big GVC:GVC Holdings sale erasing a chunk of paper profit. JLP:Jubilee Platinum had a healthy 9.5% increase today after announcing $50m financing for new projects. OPTI:Optibiotix had another depressing drop, and even IQE:IQE were very naughty, as my disappointment at missing out on the purchase was tempered by an 8p rise in share price, until I got home and found all today's gains had vanished by close of play. If the price tanks now then I may not be holding TLOU:Tlou Energy very long so I can revert to plan A!
It's been a busy week already - and still 2 days to go...
Monday 7 August 2017
Fond farewell to GVC Holdings
I seem to get this itch when I transition into a new year, and so on the day I transitioned from year 2 to year 3, I decided to sell GVC:GVC Holdings.
This has been such a great share for me. I bought in at around 422p and sold about a third of my holding for 543.5p making £236 (27.5%) on those.
I later bedded the rest into my ISA, selling at 685p and making an amazing £1,499 (63.9%) profit.
However, that doesn't really count as I bought them all back in my ISA for 685p and sold them today for 787.55p making £549.24 (14.2%) profit.
So I have to say "thank you" to GVC for being such a great share
Why did I sell?
I think these will continue to climb, but they have been very volatile lately and I've been getting a bit twitchy.
I also have ethical problems being invested in gambling. I'm uneasy about making profits by taking advantage of people who have an addiction. It's similar to tobacco which I avoid investing in. Clearly I'm not so opposed to it that I'm worried about making over £2,000 profit, but I'm just a little bit opposed, so feel a certain weight off my shoulders now.
Another reason for the sale was my concern over the performance of the ISA and share accounts, having dipped well below my 10% target for sales and dividends. This sale has taken the average up to 9.7% which is far more healthy.
So I ended up with around £4,300 in my account to do something interesting with.
My first purchase was MTFB:Motif Bio. I've been watching these for a while and they are pretty close to getting approval for a new antibiotic with a potential $1b market. Given trial results so far, these appear to be relatively de-risked for a junior pharma, and the price tanked a bit recently due to a placing, so now seemed like the ideal time to buy. I purchased 3,411 shares at 28.9638p costing £999.91. They ended the day on a bid price of 28.75 so the spread has almost been caught up already.
My next purchase was meant to be some more IQE:IQE which had taken a dip on Friday and I figured now was a good time to strike. However that was scuppered by an article in the Telegraph yesterday which caused the share price to soar early on. It went as high as 118.5p at one point. It ended the day at 114.5p bid price which sent my portfolio rocketing and immediately removed the paper loss from selling GVC:GVC Holdings, in fact the combined portfolios are up by £563 so in reality they would have climbed over £1,000 today. So I didn't buy the shares but have kept some cash back so I'm ready to strike if they have a post-article dip or a tree shake. I may set up a limit order in case I'm busy when the dip happens. I'll set it at 104p which is what I hoped to buy for.
So that left me with another £2,000. What on earth could I do with it? Well the question was answered for me when OPTI:Optibiotix dropped to 61p. How could I stand by and miss an opportunity like that? I bought another 3,207 shares at the ridiculous price of 61.98p costing £1,999.65. This has brought my average price in the ISA account down from 71.8p to 70.3p.
Imagine my joy when I got in tonight to find the price had ended up in the blue and a bid price of 64.5p. I think this is the first time OPTI:Optibiotix has done something nice for me in the long, tortured time I've been holding. I rather hope this is a habit it will nurture and grow!
Needless to say this takes OPTI:Optibiotix to 36.6% of my entire portfolio with 33,259 shares costing £23,352 and currently losing £1,936. How long will they be losing money? Will I get another chance to accumulate? How many free SBTX:SkinBiotherapeutics shares will I get? More to the point, how many free Sweetbiotix shares will I get, coz that's the big one! The strange price action we saw today could have been a large order filling, although I would have thought it would have been more difficult to buy on-line if that was the case. Given that my purchase is showing as a sell, you can't believe a word you read on the trading lists - an issue which I think is utterly scandalous!
That's it for an exciting day - just need to watch IQE:IQE like a hawk now, so I'm ready to pounce for more...
This has been such a great share for me. I bought in at around 422p and sold about a third of my holding for 543.5p making £236 (27.5%) on those.
I later bedded the rest into my ISA, selling at 685p and making an amazing £1,499 (63.9%) profit.
However, that doesn't really count as I bought them all back in my ISA for 685p and sold them today for 787.55p making £549.24 (14.2%) profit.
So I have to say "thank you" to GVC for being such a great share
Why did I sell?
I think these will continue to climb, but they have been very volatile lately and I've been getting a bit twitchy.
I also have ethical problems being invested in gambling. I'm uneasy about making profits by taking advantage of people who have an addiction. It's similar to tobacco which I avoid investing in. Clearly I'm not so opposed to it that I'm worried about making over £2,000 profit, but I'm just a little bit opposed, so feel a certain weight off my shoulders now.
Another reason for the sale was my concern over the performance of the ISA and share accounts, having dipped well below my 10% target for sales and dividends. This sale has taken the average up to 9.7% which is far more healthy.
So I ended up with around £4,300 in my account to do something interesting with.
My first purchase was MTFB:Motif Bio. I've been watching these for a while and they are pretty close to getting approval for a new antibiotic with a potential $1b market. Given trial results so far, these appear to be relatively de-risked for a junior pharma, and the price tanked a bit recently due to a placing, so now seemed like the ideal time to buy. I purchased 3,411 shares at 28.9638p costing £999.91. They ended the day on a bid price of 28.75 so the spread has almost been caught up already.
My next purchase was meant to be some more IQE:IQE which had taken a dip on Friday and I figured now was a good time to strike. However that was scuppered by an article in the Telegraph yesterday which caused the share price to soar early on. It went as high as 118.5p at one point. It ended the day at 114.5p bid price which sent my portfolio rocketing and immediately removed the paper loss from selling GVC:GVC Holdings, in fact the combined portfolios are up by £563 so in reality they would have climbed over £1,000 today. So I didn't buy the shares but have kept some cash back so I'm ready to strike if they have a post-article dip or a tree shake. I may set up a limit order in case I'm busy when the dip happens. I'll set it at 104p which is what I hoped to buy for.
So that left me with another £2,000. What on earth could I do with it? Well the question was answered for me when OPTI:Optibiotix dropped to 61p. How could I stand by and miss an opportunity like that? I bought another 3,207 shares at the ridiculous price of 61.98p costing £1,999.65. This has brought my average price in the ISA account down from 71.8p to 70.3p.
Imagine my joy when I got in tonight to find the price had ended up in the blue and a bid price of 64.5p. I think this is the first time OPTI:Optibiotix has done something nice for me in the long, tortured time I've been holding. I rather hope this is a habit it will nurture and grow!
Needless to say this takes OPTI:Optibiotix to 36.6% of my entire portfolio with 33,259 shares costing £23,352 and currently losing £1,936. How long will they be losing money? Will I get another chance to accumulate? How many free SBTX:SkinBiotherapeutics shares will I get? More to the point, how many free Sweetbiotix shares will I get, coz that's the big one! The strange price action we saw today could have been a large order filling, although I would have thought it would have been more difficult to buy on-line if that was the case. Given that my purchase is showing as a sell, you can't believe a word you read on the trading lists - an issue which I think is utterly scandalous!
That's it for an exciting day - just need to watch IQE:IQE like a hawk now, so I'm ready to pounce for more...
Friday 4 August 2017
Week 104 Review - The rise is halted
On Wednesday evening this was looking like another great week, with IQE:IQE continuing the march upwards and everything else relatively flat leaving the combined portfolios up by £800. Yesterday saw £600 of that wiped out and today saw the rest go too. The week ended £152 down on last, which I think we can call a flat week, but the upward momentum has paused (I hope - rather than stopped). The total portfolio value stands at £68,009 so the buffer between profit and loss is now £3,424.
Worst performer was JLP:Jubilee Platinum despite a reasonable trading update. The problem is everyone was expecting a great trading update so the share price tanked. It recovered over the week but my holding still ended up 7% down.
TND:Tandem Group reversed recent good performance and dropped 5% and OPTI:Optibiotix fell a bit further by 2% to the point where I start feeling twitchy about buying some more.
There were some small rises around, and BLUR:Blur Group increased in value by 5% after their CEO left and the share price rocketed - for people who bought at the bottom. For me the potential profit went from 5p to £5 but is still 95% down on my purchase price. I only keep them to remind me how stupid I was when I first started out.
Share of the Week was KIBO:Kibo Mining, climbing 7% in my ISA but 10% in my share account. I think people are sensing that some news is brewing. A licence could see this get back into profit for me.
You can hardly even see the dip
Here's the ISA and share portfolios after exactly 2 years
A tiny loss of £176 and mostly caused by deepening losses of JLP:Jubilee Platinum and OPTI:Optibiotix, as profits were up by £218 thanks to small increases across the likes of IQE:IQE, GVC:GVC Holdings and KIBO:Kibo Mining getting into profit in the share account. A nice quarterly dividend of £10.53 came from CMCL:Caledonia Mining, although their entry to the NY Stock Exchange has been a massive damp squib, with no increase in share price whatsoever.
Just about stayed in the black by £648
The SIPP looks like this after week 88
Potential profits up £99 from LGEN:Legal and General rising 4% and a tiny rise for IQE:IQE. OPTI:Optibiotix spoiled the fun, with deepening losses dragging that down to just £23 overall. Year 2 is now officially going worse than year 1 did for realised profits, but paper profits are at 18.4% which is brilliant.
The gap stays nice and wide
Here's the dreaded trading portfolio after week 54 - prop open your eyes now.
All that happened was my average losses dropped by 3p a month
Yawn...
Next week LGEN:Legal & General publish their interims on Wednesday. The 4% rise this week could be geared to that, and so I wouldn't be surprised if there isn't a corresponding drop-off on Wednesday. I can afford a bit of a drop anyway as they are 35% up and the investment is 42% up if you include the healthy dividends.
I could really do with OPTI:Optibiotix announcing something. A week of no news has seen the share price slide further, and with IQE:IQE probably having peaked, OPTI:Optibiotix is my best bet to recharge the upward momentum. There's also a possibility the news KIBO:Kibo Mining have been hinting at in the last few updates will arrive, and that the tree-shake of JLP:Jubilee Platinum is complete to allow some recovery there. At this tine of year I suspect it's more likely things will stagnate for another week.
Worst performer was JLP:Jubilee Platinum despite a reasonable trading update. The problem is everyone was expecting a great trading update so the share price tanked. It recovered over the week but my holding still ended up 7% down.
TND:Tandem Group reversed recent good performance and dropped 5% and OPTI:Optibiotix fell a bit further by 2% to the point where I start feeling twitchy about buying some more.
There were some small rises around, and BLUR:Blur Group increased in value by 5% after their CEO left and the share price rocketed - for people who bought at the bottom. For me the potential profit went from 5p to £5 but is still 95% down on my purchase price. I only keep them to remind me how stupid I was when I first started out.
Share of the Week was KIBO:Kibo Mining, climbing 7% in my ISA but 10% in my share account. I think people are sensing that some news is brewing. A licence could see this get back into profit for me.
You can hardly even see the dip
Here's the ISA and share portfolios after exactly 2 years
| Weekly Change | |||
| Portfolio cost | £46,246.68 | +£0 | |
| Portfolio sell value (bid price - commission) | £46,553.64 | (+0.7%) | -£176.71 |
| Potential profits | £7,264.12 | +£218.76 | |
| Yr 2 Dividends | £511.12 | +£10.53 | |
| Yr 2 Profit from sales | £2,872.24 | +£0 | |
| Yr 2 Average monthly cash profit | £278.20 | (7.2%) | -£4.88 |
| Total Dividends | £1,179.05 | +£10.53 | |
| Total Profit from sales | £6.712.50 | +£0 | |
| Average monthly cash profit | £324.43 | (8.4%) | -£2.86 |
| (Sold stocks profit + Dividends - Fees / Months) |
A tiny loss of £176 and mostly caused by deepening losses of JLP:Jubilee Platinum and OPTI:Optibiotix, as profits were up by £218 thanks to small increases across the likes of IQE:IQE, GVC:GVC Holdings and KIBO:Kibo Mining getting into profit in the share account. A nice quarterly dividend of £10.53 came from CMCL:Caledonia Mining, although their entry to the NY Stock Exchange has been a massive damp squib, with no increase in share price whatsoever.
Just about stayed in the black by £648
The SIPP looks like this after week 88
| Weekly Change | |||
| Portfolio cost | £17,853.50 | +£0 | |
| Portfolio sell value (bid price - commission) | £21,133.96 | (18.4%) | +£23.94 |
| Potential profits | £5,126.67 | +£99.76 | |
| Yr 2 Dividends | £294.96 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£0 | |
| Yr 2 Average monthly cash profit | £220.73 | (14.8%) | -£6.30 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £3,946.67 | +£0 | |
| Average monthly cash profit | £223.86 | (15.0%) | -£2.57 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits up £99 from LGEN:Legal and General rising 4% and a tiny rise for IQE:IQE. OPTI:Optibiotix spoiled the fun, with deepening losses dragging that down to just £23 overall. Year 2 is now officially going worse than year 1 did for realised profits, but paper profits are at 18.4% which is brilliant.
The gap stays nice and wide
Here's the dreaded trading portfolio after week 54 - prop open your eyes now.
| Weekly Change | |||
| Portfolio cost | £486.05 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £321.65 | (-34%) | +£0 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.74 | (-4.3%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
All that happened was my average losses dropped by 3p a month
Yawn...
Next week LGEN:Legal & General publish their interims on Wednesday. The 4% rise this week could be geared to that, and so I wouldn't be surprised if there isn't a corresponding drop-off on Wednesday. I can afford a bit of a drop anyway as they are 35% up and the investment is 42% up if you include the healthy dividends.
I could really do with OPTI:Optibiotix announcing something. A week of no news has seen the share price slide further, and with IQE:IQE probably having peaked, OPTI:Optibiotix is my best bet to recharge the upward momentum. There's also a possibility the news KIBO:Kibo Mining have been hinting at in the last few updates will arrive, and that the tree-shake of JLP:Jubilee Platinum is complete to allow some recovery there. At this tine of year I suspect it's more likely things will stagnate for another week.
Subscribe to:
Posts (Atom)